Former Director Kaye Notices Sale of 1.5M Shares (~$38M) After Option Exercise
STOK sits 26% above its 52-week low of $20.32 on elevated volume (2.4× avg).
Summary
Former director Edward Kaye plans to sell 1.5M Stoke shares (~$38M) acquired through a cashless option exercise, a much larger disposition than his prior tax-related sale.
Key Events · Ownership and Investor Activity · STOK
-
Former Director Notices 1.5M-Share Sale
Edward Kaye filed a Form 144 to sell 1,496,042 shares with an approximate market value of $38.4M, per the filing's calculated figures.
-
Shares From Cashless Option Exercise
The shares were acquired on 10/21/2026 through exercise of options under a registered plan, with the sale of underlying shares commencing the same day.
-
Size Relative to Share Count
The proposed sale equals about 2.3% of the 64,526,242 shares outstanding stated in the filing (1,496,042 / 64,526,242).
-
Prior Sale Was Tax-Related
Kaye's only sale in the past three months was 12,567 shares for $402,521 on 08/14/2026, tied to tax withholding; this notice is far larger.
Analysis · STOK · Life Sciences
Edward Kaye, who left Stoke's board in September 2026, has filed notice to sell 1,496,042 shares worth roughly $38.4M at today's $25.68 price — about 2.3% of the 64.5M shares outstanding stated in the filing. Because the shares come from a cashless exercise of options under a registered plan, this is insider monetization rather than a tax-withholding cleanup like his $402K August sale. The overhang is large relative to his prior activity and arrives while the stock trades near recent highs after positive zorevunersen regulatory news. Still, as a former affiliate's planned disposition, it says little about the operating outlook.
How filings like this one have moved
In the 30 days to Oct 21, 2026, 28.9% of the 1511 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.54%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, STOK was trading at $25.68 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.7B. The 52-week trading range was $20.32 to $40.22. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.